Home › Clot risk in Lilly lung-cancer drug raises FDA concerns
 

Keywords :   


Clot risk in Lilly lung-cancer drug raises FDA concerns

2015-07-07 21:33:35| Biotech - Topix.net

Eli Lilly and Co.' s experimental lung cancer drug has raised concerns with U.S. regulators that it may increase patients' risk of suffering potentially deadly blood clots.

Tags: risk drug concerns raises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »